Collection Sites Launches Operating Partnership To Extend COVID-19 Testing With Besser Brands; Medivolve Closes Noble Bioscience Transaction
March 02, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) announces the launch of an operating model with Besser Brands in the state of...
Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement
February 19, 2021 17:00 ET
|
Medivolve Inc.
TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) announces the cancellation of the agreement to acquire 100% of Karland Health,...
Medivolve Announces Launch of Investor Awareness Campaign
February 18, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of an investor marketing campaign to...
Medivolve Announces Webinar to Discuss Telehealth Strategy
February 16, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce it is hosting a Corporate Update webinar, Monday,...
Medivolve Enters into Agreement to Acquire Karland Health, Enabling its Wholly Owned Subsidiary, Collection Sites, to Expand Services Beyond COVID-19 Testing with Telehealth and Remote Patient Monitoring
February 11, 2021 08:19 ET
|
Medivolve Inc.
TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce that it has signed a binding letter of intent to...
Collection Sites Provides Update With January Sales of 73,973 Tests at an Average Price of $96 per Test
February 04, 2021 07:30 ET
|
Medivolve Inc.
To date Collection Sites has launched a total of 62 sites across its network with additional new openings in Texas, Florida, and North Carolina. Further, Medivolve will host a webinar today, Thursday,...
Medivolve Enters Into Agreement to Acquire 100% of Noble Bioscience Corp. and Its Agency Rights to Nuturell’s COVID-19 Surface Shield Technology
February 02, 2021 09:30 ET
|
Medivolve Inc.
Nuturell’s non-toxic silver surface shield technology is a COVID-19 disinfectant that converts into a protective shield when air dry, killing the coronavirus among other pathogens for up to 90 days...
Medivolve Announces Webinar Introducing Newest Partners: Marvel Diagnostics, Startup Out of UCLA
February 01, 2021 12:33 ET
|
Medivolve Inc.
Medivolve will host a webinar Thursday, February 4th at 1 pm ET. This includes an overview of Collection Sites’ network growth and a presentation from the UCLA researchers behind the Marvel...
Medivolve Announces Investment Into Marvel Diagnostics and Its Non-Invasive Exhaled Breath Diagnostic Technology
January 28, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce a share purchase agreement to acquire up to 40% of Marvel Diagnstics...
Collection Sites Continues Expansion With Launch of New COVID-19 Testing Sites in Florida, Virginia and Texas
January 27, 2021 07:30 ET
|
Medivolve Inc.
TORONTO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of new COVID-19 testing centres by its wholly owned...